Filing metadata

Accession number
0001610717-24-000192
Form type
Form 4/A
Filer
AN2 Therapeutics, Inc.
CIK
CIK 1880438
Filed
Mar 29, 2024
Reporting period
Mar 15, 2024
Description
Insider transaction

Explore SEC Filings Hub